Parimbir S Dulai, MD
Disclosures: Consulting Fee-Takeda Pharmaceuticals (Any division)|Consulting Fee-Pfizer (Any division)|Consulting Fee-AbbVie (Any division)|Consulting Fee-Janssen (Any division)|Consulting Fee-Gilead Sciences, Inc.|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Lilly (Any division)|Consulting Fee-Novartis Corporation Pharmaceuticals|Stocks or stock options, excluding diversified mutual funds-Digbihealth|Royalties or Patent Beneficiary-PreciDiag - 08/26/2022

Parambir Dulai, MD, is an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at Northwestern University. He serves as the Director of GI Clinical Trials and Precision Medicine, as well as the director of the Digestive Health Foundation Biorepository. He completed his internal medicine residency and chief residency at Dartmouth, and subsequently completed an NIH T32 research fellowship at University of California San Diego followed by an IBD Clinical Fellowship. He went on to complete a clinical trials fellowship at Robarts Clinical Trials. He has a robust research program focusing on pragmatic clinical trials and biomarker discovery, and his NIH funded lab focuses on emerging approaches to studying spatial biology in immune mediated inflammatory diseases.